ALCAlcon AG

NYSE · US · Healthcare · Medical Instruments & Supplies · alcon.com

73.63USDMkt Cap: 35.59B $P/E: 56.213d ago

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. It offers equipment, instrumentation and diagnostics…

Industry Peers

Medical Instruments & Supplies

Screen all

ISRG

Intuitive Surgical, Inc.

$135.72BUSDP/E 43.4

EssilorLuxottica Societe anonyme

$81.53BUSDP/E 30.5

BDX

Becton, Dickinson and Company

$52.30BUSDP/E 33.2

MDLN

Medline Inc. Class A Common Stock

West Pharmaceutical Services, Inc.

$24.85BUSDP/E 45.2

DIM

Sartorius Stedim Biotech

$20.46BUSDP/E 64.5

SRT3

Sartorius Aktiengesellschaft

Sartorius Aktiengesellschaft

$14.73BUSDP/E 69.1

SOLV

Solventum Corporation Common Stock

$15.25BUSDP/E 10.9

COO

The Cooper Companies, Inc.

$14.87BUSDP/E 64.6

BAX

Baxter International Inc.

$13.62BUSD

ALGN

Align Technology, Inc.

Stevanato Group S.p.A. Ordinary Shares

$6.17BUSDP/E 39.6

BLCO

Bausch + Lomb Corporation Common Shares

$6.16BUSD

Key Statistics

Company

Market Cap35.59B $

Enterprise Value39.44B $

Revenue (TTM)10.86B $

Gross Profit5.75B $

Net Income (TTM)980.00M $

Revenue/Share22.21 USD

Last Price73.63 USD

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees25.0K

CountryUS

SectorHealthcare

IndustryMedical Instruments & Supplies

ISINCH0432492467

Valuation

P/E (Trailing)56.21

P/E (Forward)18.52

PEG1.49

EV/EBITDA16.40

EV/Revenue3.63

P/S3.28

P/B1.65

EPS (TTM)1.31

EPS (Forward)3.97

52W Range

72.6483% of range73.84

52W High73.84 USD

52W Low72.64 USD

Profitability

Gross Margin55.24%

Oper. Margin14.63%

EBITDA Margin22.13%

Profit Margin9.42%

ROE4.45%

ROA3.11%

Growth

Revenue Growth8.70%

Earnings Growth—

Cash Flow & Leverage

Operating CF2.27B $

CapEx (TTM)663.00M $

FCF Margin11.72%

FCF Yield3.58%

Net Debt3.84B $

Net Debt/EBITDA1.60

Balance Sheet

Debt/Equity0.02

Current Ratio2.09

Quick Ratio1.12

Book Value/Sh44.67 USD

Cash/Share3.014 USD

Dividends

Fwd Div Rate0.3600 USD

Trail. Div Rate0.3530 USD

Div. Yield0.49%

5Y Avg Yield0.29%

Payout Ratio27.03%

Ex-Div DateMay 6, 2026

Pay DateMay 7, 2026

Analyst Consensus

Rating1.6 (Buy)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)85.24 USD

Upside (mean)+15.8%

Target Range62.00 USD – 103.00 USD

$62.00+15.8% to mean$103.00

# Analysts15

Ownership

Shares Out.483.40M

Float481.83M

Insiders0.20%

Institutions66.10%

Short Interest

Short Ratio5.9d

Short % Out.2.83%

Shares Short13.01M

Short (prev mo.)10.39M

Technical

SMA 5069.15 (+6.5%)

SMA 20074.65 (-1.4%)

Beta0.69

S&P 52W Chg19.18%

Avg Vol (30d)907.29K

Avg Vol (10d)2.04M

Technical Indicators

RSI (14)—

MACD—

MACD Signal—

MACD Hist.—

BB Upper—

BB Middle—

BB Lower—

BB Width—

ATR (14)—

Vol Ratio (20d)—